Improved survival of systemic sclerosis-associated pulmonary arterial hypertension (SSC-PAH) in the endothelin antagonist era

被引：0
|
作者：
Williams, MH
Das, C
Handler, CE
Akram, MR
Davar, J
Denton, CP
Smith, CJ
Black, CM
Coghlan, JG
机构：
[1] Royal Free Hosp, Acad Dept Rheumatol & Populat Sci, Dept Cardiol, London, England
[2] UCL Med Sch, London, England
来源：
HEART | 2005年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A64 / A65
页数：2
相关论文
共 50 条
  • [1] A Systemic Review of Factors Associated with Systemic Sclerosis-associated Pulmonary Arterial Hypertension (SSc-PAH)
    Jiang, Yuxuan
    Turk, Matthew
    Pope, Janet
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] Survival of patients with systemic sclerosis-associated pulmonary arterial hypertension has improved in the endothelin antagonist era
    Williams, M. H.
    Das, C.
    Handler, C. E.
    Akram, M. R.
    Denton, C. P.
    Smith, C. J.
    Black, C. M.
    Coghlan, J. G.
    EUROPEAN HEART JOURNAL, 2005, 26 : 113 - 113
  • [3] Impact of Immunosuppressive Treatment on Development and Survival in Systemic Sclerosis Associated Pulmonary Arterial Hypertension (SSc-PAH)
    Rodolfi, Stefano
    Ng, Cheryl Chun Man
    Bejerano, Ana Maria Ruiz
    Kanitkar, Medha
    Ong, Voon
    Denton, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3238 - 3239
  • [4] Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
    Sobanski, Vincent
    Launay, David
    Hachulla, Eric
    Humbert, Marc
    CURRENT RHEUMATOLOGY REPORTS, 2016, 18 (02) : 1 - 14
  • [5] Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
    Vincent Sobanski
    David Launay
    Eric Hachulla
    Marc Humbert
    Current Rheumatology Reports, 2016, 18
  • [6] Utility of factor D and other alternative complement factors as biomarkers in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH)
    Petrow, Eva
    Feng, Changyong
    Frazer-Abel, Ashley
    Marangoni, Roberta Goncalves
    Lutz, Katie
    Nichols, William C.
    Holers, V. Michael
    Ritchlin, Christopher
    White, R. James
    Korman, Benjamin D.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 69
  • [7] Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era
    Launay, David
    Sitbon, Olivier
    Hachulla, Eric
    Mouthon, Luc
    Gressin, Virginie
    Rottat, Laurence
    Clerson, Pierre
    Cordier, Jean-Francois
    Simonneau, Gerald
    Humbert, Marc
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (12) : 1940 - 1946
  • [8] Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc)
    Jiang, Yuxuan
    Turk, Matthew A.
    Pope, Janet E.
    AUTOIMMUNITY REVIEWS, 2020, 19 (09)
  • [9] The Differences Between Systemic Sclerosis Associated Pulmonary Arterial Hypertension (ssc-Pah) And Idiopathic Pulmonary Arterial Hypertension (ipah): A Quantitative Lung Morphometric Analysis
    Argula, R. G.
    Harley, R. A.
    Silver, R. M.
    Strange, C. B.
    Ramakrishnan, V. R.
    Feghali-Bostwick, C. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [10] Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: For Real?
    Xanthouli, Panagiota
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (03) : 238 - 240
12345